Language:

Optic Nerve Sheath Diameter and Acute Mountain Sickness

Wilderness & environmental medicine, 2013-06, Vol.24 (2), p.105-111 [Peer Reviewed Journal]

Wilderness Medical Society ;2013 Wilderness Medical Society ;The Author(s) 2013 ;Copyright © 2013 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved. ;ISSN: 1080-6032 ;EISSN: 1545-1534 ;DOI: 10.1016/j.wem.2012.11.003 ;PMID: 23425353

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Optic Nerve Sheath Diameter and Acute Mountain Sickness
Author: Keyes, Linda E., MD ; Paterson, Ryan, MD ; Boatright, Dowin, MD ; Browne, Vaughn, MD, PhD ; Leadbetter, Gig, PhD ; Hackett, Peter, MD
Subjects: Acute Disease ; acute mountain sickness ; Adolescent ; Adult ; Aged ; Altitude Sickness - diagnosis ; Altitude Sickness - therapy ; Case-Control Studies ; cerebral edema ; Cohort Studies ; Emergency ; high altitude ; Humans ; hypoxia ; Intracranial Hypertension - diagnosis ; intracranial pressure ; Intracranial Pressure - physiology ; Middle Aged ; Optic Nerve - anatomy & histology ; Optic Nerve - diagnostic imaging ; optic nerve sheath diameter ; Oxygen Inhalation Therapy ; Treatment Outcome ; Ultrasonography ; Young Adult
Is Part Of: Wilderness & environmental medicine, 2013-06, Vol.24 (2), p.105-111
Description: Objective Increased intracranial pressure (ICP) may contribute to acute mountain sickness (AMS). Measuring optic nerve sheath diameter (ONSD) by ultrasound (US) is a noninvasive technique to detect elevated ICP, and increased ONSD has been associated with AMS. We hypothesized that ONSD would increase with acute, rapid ascent to 4300 m and that increased ONSD would be associated with symptoms of AMS. We further hypothesized that treatment with oxygen at 4300 m would reduce symptoms and ONSD. Methods A cohort study was performed comparing US measurement of ONSD in healthy subjects at 1400 m and 18 hours after rapid ascent to 4300 m, both before and after oxygen treatment and between subjects with and without AMS (Lake Louise Score ≥3). Results Among 57 subjects, 29 (51%) experienced AMS after rapid ascent to 4300 m. In subjects without AMS, mean ONSD did not increase at 4300 m. In subjects with AMS, mean ONSD increased at 4300 m and was higher than in those without AMS. Treatment with oxygen lowered mean ONSD in subjects with AMS but not in those without AMS. Individual responses to altitude and oxygen varied greatly within groups, and the relationship between ONSD and AMS symptoms was weak. Conclusions In this controlled study, mean ONSD increased in subjects with AMS at high altitude. However, individual variation was high, and most ONSD values were below the clinical threshold for raised ICP. Observed differences were small, of questionable clinical importance, and within the range of precision of the US machine. Overall, our data do not support a role for increased ICP in mild to moderate AMS.
Publisher: Los Angeles, CA: Elsevier Inc
Language: English
Identifier: ISSN: 1080-6032
EISSN: 1545-1534
DOI: 10.1016/j.wem.2012.11.003
PMID: 23425353
Source: Geneva Foundation Free Medical Journals at publisher websites
MEDLINE
Open Access: Freely Accessible Journals by multiple vendors

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Optic Nerve Sheath Diameter and Acute Mountain Sickness

Wilderness Medical Society ;2013 Wilderness Medical Society ;The Author(s) 2013 ;Copyright © 2013 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved. ;ISSN: 1080-6032 ;EISSN: 1545-1534 ;DOI: 10.1016/j.wem.2012.11.003 ;PMID: 23425353

Searching Remote Databases, Please Wait